$INJ Injective Protocol (INJ) is a high-performance Layer 1 blockchain specifically designed for decentralized finance (DeFi) applications. Built on Cosmos SDK, it can process over 25,000 transactions per second thanks to its Tendermint-based Proof-of-Stake (PoS) consensus mechanism. This structure offers fast transaction confirmations and low transaction fees.  
Key Features
• Decentralized Order Book: Injective adopts the order book model used in traditional exchanges instead of automated market makers (AMM) like Uniswap. This provides a more transparent and efficient trading experience. 
• Cross-Chain Compatible: It integrates with different blockchains such as Ethereum, Polkadot, and Solana, allowing users to buy and sell various assets on a single platform. 
• Developer-Friendly Infrastructure: With Cosmos SDK and CosmWasm support, developers can create customizable and scalable DeFi applications. 
INJ Token Usage Areas
• Governance: INJ token holders can participate in decision-making processes regarding the future of the protocol. 
• Staking: By staking INJ tokens, you can contribute to network security and earn rewards.
• Transaction Fees: INJ tokens are used for transactions on the platform, which helps users reduce transaction fees. 
History and Developments
Injective Protocol was founded in 2018 by Eric Chen and Albert Chon. The project took part in Binance Labs' first incubation program and received support from investors such as Mark Cuban. In 2023, a $150 million ecosystem fund was launched to expand the DeFi infrastructure.  
Current Status
As of April 2025, the price of the INJ token is approximately $9.15 and the market value is approximately $915 million. The circulating supply is approximately 99.9 million INJ.
